Addressing the Underdiagnosis of Alcohol Use Disorder During and After Pregnancy
Recent research reveals significant gaps in the treatment of alcohol use disorder during pregnancy and postpartum, highlighting urgent needs for improved care and support.
Alcohol use disorder (AUD) remains significantly undertreated among pregnant women and new mothers, posing substantial risks to both parents and infants. Despite the availability of evidence-based treatments, including pharmacotherapy and counseling, their utilization during pregnancy is surprisingly low. This gap is partly due to the lack of clear clinical guidelines, limited data on the safety of AUD medications during pregnancy, and prevalent stigma surrounding substance use in pregnant populations.
Recent research analyzing a comprehensive national medical claims database highlighted troubling trends in treatment patterns. The study compared treatment rates between pregnant women and non-pregnant peers, finding that the proportion receiving alcohol-related medication dropped sharply during pregnancy, with only 0.3% of pregnant women on such treatments by the third trimester, compared to 8% of non-pregnant women. After childbirth, treatment rates increased slightly but remained low.
The findings suggest that pregnancy is not necessarily a window of opportunity for engaging women in AUD treatment, as often assumed, but may instead be associated with treatment discontinuation. These gaps in care during pregnancy and postpartum emphasize the urgent need for improved treatment strategies, better guidelines, and reduced stigma to protect entire families from the dangerous consequences of untreated AUD.
For further details, refer to the study published in Alcohol, Clinical and Experimental Research (2025). Source
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Large Language Models Demonstrate Potential in Predicting Liver Cancer Treatment Outcomes
Emerging research reveals that large language models like GPT-4 can accurately predict liver cancer treatment responses, aiding personalized oncology care and decision-making.
Breast Tumors Exploit Fat Cells for Growth: Can We Halt This Process?
UCSF researchers reveal how aggressive breast tumors hijack nearby fat cells by forming molecular tunnels to access energy, offering new potential for targeted therapies.
Innovative Breath Test Shows Promise in Detecting Blood Cancers
A groundbreaking breath analysis method offers a rapid, non-invasive approach to detecting blood cancers, potentially transforming diagnosis especially in resource-limited settings.
Research Reveals Bias in ICU Delirium Screening for Spanish-Speaking Patients
New research at ATS 2025 uncovers language-based disparities in ICU delirium screening, highlighting the effectiveness of culturally adapted assessment tools for Spanish-speaking patients.